Abstract
Unilamellar or multilamellar vesicles prepared from synthetic non-ionic surfactants can be considered to be synthetic surfactant analogues of liposomes (Baillie, 1988; Florence and Baillie, 1989). The exploration of alternatives to phospholipids as the main lipid moiety in the fabrication of vesicles is in itself worthwhile, particularly as phospholipid raw materials are naturally occurring substances, not always in plentiful supply, and may be unstable during storage and processing. Methods for the processing of lipid raw material, for synthesizing, modifying and purifying natural lipids, are important for the ultimate large-scale clinical use of phospholipid-based vesicular delivery. Moreover, by studying the behaviour of vesicles constructed from nonionic surfactants (or other lipid species) there is the potential to determine what are the key chemical and physical factors which control biological distribution and targeting.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Azmin, M.N., Florence, A.T., Handjani-Vila, R.M., Stuart, J.F.B., Vanlerberghe, G. and Miittaker, J.A., 1985, The effect of non-ionic surfactant vesicle (biosome) entrapment on the absorption and distribution of methotrexate in mice, J.Pharm.Pharmacol., 37:237.
Azmin, M.N., Florence, A.T., Handjani-Vila, R.M., Stuart, J.F.B., Vanlerberghe, G. and Whittaker, J.S., 1986, The effect of niosanes and polysorbate 80 on the metabolism and excretion of methotrexate in the mouse, J.Microencap., 3:95.
Baillie, A.J., 1988, Niosomes: a putative drug carrier system, in: “Targeting of Drugs”, G. Gregoriadis and G. Poste, eds.. Plenum, New York.
Baillie, A.J., Florence, A.T., Hume, L.R., Muirhead, G. and Rogerson, A., 1985, The preparation and properties of niosomes — non-ionic surfactant vesicles, J.Pharm.Pharmacol., 37:863.
Baillie, A.J., Coombs, G.H., Dolan, T.F. and Laurie, J., 1986, Nonionic surfactant vesicles, niosomes, as a delivery system for the anti- leishnianial drug, sodium stibogluconate, J.Pharm.Pharmacol., 38:502.
Burkhanov, S.A., Kosykh Repin, V.S., Saatov, T.S., Totchilin, V.P., 1988, Interaction of liposomes of different phospholipid and ganglioside composition with rat hepatocytes. Int.J.Pharmaceutics, 46:31.
Cable, C. and Florence, A.T., 1988, Mixed poly(glycerol)-poly(oxyethylene) ether nioscmies, J.Pharm.Hiarmacpl., 40:30P.
Cable, C., Cassidy, J., Kaye, S.B. and Florence, A.T., 1988, Doxorubicin in cholesteryl polyoxyethylene ether modified niosomes: evidence of enhancement of absorption in mice? J.Pharm.Pharmacol., A0:31P.
Carter, K.C., Baillie A.J., Alexander, J. and Dolan, T.F., 1988, The therapeutic effect of sodium stibogluconate in BALB/c mice infected with Leishmania donovani is organ-dependent, J.Pharm.Pharmacol., 40:370.
Chathan, S. and Lawrence, M.J., 1989, The preparation of polyoxyethylene containing non-ionic surfactant vesicles, J.Pharm.Pharmacol., 41:6P.
Echegoyan, L.E., Hernandez, J.C., Kaifer, A.E., Gokel, G.W. and Echegoyan, L., 1988, Aggregation of steroidal lariat ethers: the first example of nonionic liposomes (niosomes) formed from neutral crown ether compounds, J.Chem.Soc.Chem.Coimiun., 836.
Florence, A.T. and Baillie, A.J., 1989, Nonionic surfactant vesicles — alternatives to liposomes in drug delivery? to: “Novel Drug Delivery and its Therapeutic Applications”, L.F. Prescott and W.S. Nimmo, eds., Wiley, Chichester.
Friedman-Kien, A.E., Laubenstein, L.J., Rubinstein, P., 1980, Disseminated Kaposi s sarcoma in homosexual men, Ann.Intern.fed., 96:693.
Handjani-Vila, R.M., Ribier, A., Rondot, B. and Vanlerberghe, G., 1979, Dispersion of lamellar phases of nonionic lipids in cosmetic products, Int.J.Cosmet.Sci., 1:303.
Hofland, J.E.J., Bowstra, J.A., Hodde, H., Spres, F., Junginger, H.E., 1989, Nonionic surfactant vesicles in transdermal formulations: controlled release and in vitro effects on human skin, Pharm.Res., 6:S.178.
Hunter, C.A., Dolan, T.F., Coombs, G.H. and Baillie, A.J., 1988, Vesicular systems (niosomes and liposanes) for delivery of sodium stibogluca- mate in experimental murine visceral leishmaniasis, J.Pharm. Pharmacol., 40:161.
Ilium, L., Jacobsen, L.O., Muller, R.H., Mak, E. and Davis, S.S., 1987, Surface characteristics and the interaction of colloidal particles with mouse peritoneal macrophages, Biomaterials, 8:113.
Kerr, D.J., Rogerson, A., Morrison, G.J., Florence, A.T. and Kaye, S.B., 1988, Antitumour activity and pharmacokinetics of niosome encapsulated adriamycin in monolayer spheroid and xenograft, Br.J.Cancer, 58:432.
Khand, L., Rogerson, A., Halbert, G.W., Baillie, A.J. and Florence, A.T., 1987, The effect of cholesterol on the release of doxorubicin from nonionic siirfactant vesicles (niosomes), J.Pharm.Pharmacol., 39(Suppl.):41P.
Muller-Goymann, C.C., 1987, The influence of the micros true ture on consistency and physical stability of an o/w cream. Acta Pharmaceutica Technologica, 33:60.
Okahata, Y., Tanamuchi, S., Nagai, M. and Kunitake, T., 1981, Synthetic bi- layer membranes prepared from dialkyl anqjhiphiles with nonionic and zwitterionic head groups, J.Colloid Interface Sei., 82:401.
Patel, K.R., Li, M.P., Schuh, J.R. and Baldeschwieler, J.D., 1984, Pharmacological efficacy of a rigid non-phospholipid liposome drug delivery system, Biochim.Biophys.Acta.,797:20.
Présant, C.A., Blayney, D., Proffitt, R.T., 1990, Preliminary report: imaging of Kaposi sarcoma and lymphoma in AIDS with indium-111- labelled liposomes. Lancet, i:1303.
Ribier, A., Handjani-Vila, R.M., Bardez, E. and Valeiir, B., 1984, Bilayer fluidity of non-ionic vesicles. An investigation by differential polarized phase fluorometry, Colloids and Syfaces, 10:155.
Roger son, A., Ctimmings, J. and Florence, A.T., 1987, Adriamycin-loaded nio- somes: drug entrapment, stability and release, J.Microencap., 4:321.
Rogerson, A., Cummings, J., Willmott, N. and Florence, A.T., 1988, The distribution of doxorubicin in mice following administration in nio- somes, J.Pharm.Pharmacol., 40:337.
Stafford, S., Baillie, A.J. and Florence, A.T., 1988, Drug effects on the size of chemically defined non-ionic surfactant vesicles, J.Riarm. Pharmacol., 40:26P.
Tucker, I.G. and Florence, A.T., 1983, Interactions of ionic and nonionic surfactants with plasma low density lipoprotein, J.Fharm.Pharmacol., 35:705.
Usselmann, B. and miler-Goymann, C.C., 1984, Struktureller aufbau von Cholesterol-Polyoxyathylenfettalkoholather-Wasser-Mschungen, Progress in Colloid and Polymer Sci., 69:56.
Vanlerbere, G., Handjani-Vila, R.M., Berthelot, C. and Sebag, H., 1972, Snithese et activite de surface comparee d’une serie de nouveaux derives non-ioniques, Proceedings of the 6th International Congress on Surface Activity, Carl Hanser Verlag, Munich.
Vanlerberghe, G., Handjani-Vila, R.M. and Ribier, A., 1978, Les “niosomes” une nouvelle familie de vesicules a base d amphiphiles non ioniques, Colloques Nationaxjx du C.N.R.S., No. 938.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Plenum Press, New York
About this chapter
Cite this chapter
Florence, A.T., Cable, C., Cassidy, J., Kaye, S.B. (1990). Non-Ionic Surfactant Vesicles as Carriers of Doxorubicin. In: Gregoriadis, G., Allison, A.C., Poste, G. (eds) Targeting of Drugs 2. NATO ASI Series, vol 199. Springer, New York, NY. https://doi.org/10.1007/978-1-4684-9001-5_11
Download citation
DOI: https://doi.org/10.1007/978-1-4684-9001-5_11
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4684-9003-9
Online ISBN: 978-1-4684-9001-5
eBook Packages: Springer Book Archive